Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Product Sizes
5 mg
£185.00
SIH-426-5MG
25 mg
£580.00
SIH-426-25MG
About this Product
SKU:
SIH-426
Additional Names:
Tyrphostin AG 1296, 6,7-Dimethoxy-3-phenylquinoxaline, 6,7-Dimethoxy-2-phenylquinoxaline
CAS Number:
146535-11-7
CE/IVD:
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Extra Details:
AG-1296 is a potent, cell-permeable inhibitor of platelet-derived growth factor receptor (PDGFR) tyrosine kinase, a key regulator of cellular proliferation, survival, and migration. While originally developed for oncology and vascular biology, AG-1296 has gained attention in neuroscience for its potential role in modulating neuroinflammation and glial cell activation-processes central to the progression of neurodegenerative diseases. PDGFR signaling is involved in the regulation of astrocytes and microglia, the primary immune cells of the central nervous system. Dysregulated PDGF signaling has been implicated in neuroinflammatory responses, blood-brain barrier dysfunction, and abnormal neuronal-glial interactions. By selectively inhibiting PDGFR, AG-1296 may attenuate these pathological processes, offering a mechanistic approach to reducing neuroinflammation and promoting neural tissue stability. Additionally, PDGF pathways are involved in neural development and repair, suggesting that AG-1296 could be used to study regenerative mechanisms in the brain. Its ability to penetrate cells and selectively block receptor activity makes it a valuable tool for dissecting the role of tyrosine kinase signaling in neurodegeneration, particularly in conditions such as Alzheimer's disease, multiple sclerosis, and gliosis-related disorders.
Molecular Weight:
266.3
Purity:
≥98%
Shipping Conditions:
Ambient
Source:
Synthetic
Storage Conditions:
-20[o]C
Supplier:
StressMarq Biosciences
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Inhibitors